Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Fosgonimeton by Athira Pharma for Dementia: Likelihood of Approval
Fosgonimeton is under clinical development by Athira Pharma and currently in Phase II for Dementia. According to GlobalData, Phase II...
Fosgonimeton by Athira Pharma for Lewy Body Dementia: Likelihood of Approval
Fosgonimeton is under clinical development by Athira Pharma and currently in Phase II for Lewy Body Dementia. According to GlobalData,...
Fosgonimeton by Athira Pharma for Parkinson's Disease: Likelihood of Approval
Fosgonimeton is under clinical development by Athira Pharma and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase...